Collaboration in active ingredients continues

SPECIALTY chemicals supplier Cognis has now exclusively licensed two new active ingredients for weight management and cognitive performance from InterMed Discovery (IMD), further expanding the company's innovation pipeline. Tests on the products are already delivering promising results, Cognis said, adding that further in vivo tests and research studies for these ingredients will be carried out later this year. Cognis has already licensed four other ingredients from IMD targeting weight management and heart health. Clinical studies for one of these projects will already begin later this year. The other licensed ingredients are currently in advanced preclinical testing and scale-up process. The sales potential is increasing for active ingredients in functional foods to support weight management and benefit heart and brain health, largely because obesity is becoming a major public health problem in many parts of the world and society as a whole is getting older. InterMed Discovery GmbH T: +49 231 9742 6060 F: +49 231 9742 6061 Email: info@intermed-discovery.com Web: www.intermed-discovery.com

FPE115

Cognis (Malaysia) Sdn Bhd T: +603 5021 0000 F: +603 8600 1008 Web: www.cognis.com

FPE114

adidas